Your session is about to expire
← Back to Search
Other
Treatment for Brain Tumor
Phase 2
Waitlist Available
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is studying how well combining topotecan and thalidomide works in treating patients with cancer that has returned or does not respond to treatment.
Eligible Conditions
- Brain Tumor
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
421 Previous Clinical Trials
163,226 Total Patients Enrolled
Pam G. Khosla, MDStudy ChairRush University Medical Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has this therapeutic process gained regulatory approval from the Food and Drug Administration?
"Due to the limited pre-clinical data, this treatment has been rated a 1 for safety; Phase 1 trials are designed to assess the drug's efficacy and its potential risks."
Answered by AI
Are researchers presently enrolling participants in this clinical investigation?
"The medical trial, which was first shared on August 1st 2000 and last updated in July 2008, is not presently taking partients according to clinicaltrials.gov; however, 435 other studies are actively recruiting at this time."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger